Shau, Wen-YiWen-YiShauCHAO LUN LAIHuang, Shih-TingShih-TingHuangChen, Shu-TingShu-TingChenLi, Jim ZJim ZLiFung, SelwynSelwynFungTse, Vicki CVicki CTseLai, Mei-ShuMei-ShuLai2023-06-012023-06-012019-09-021759-1104https://scholars.lib.ntu.edu.tw/handle/123456789/631692Evidence and treatment guidelines support the use of statins in patients with established atherosclerotic cardiovascular disease (ASCVD) for secondary prevention of subsequent cardiovascular (CV) event. However, treatment adherence and persistence are still a concern.enadherence; atherosclerosis; persistence; secondary prevention; statin[SDGs]SDG3Statin adherence and persistence on secondary prevention of cardiovascular disease in Taiwanjournal article10.1136/heartasia-2018-01117631565075WOS:000489067500004